BASEL, Switzerland, March 12 (UPI) -- Swiss pharmaceutical company Roche Holding said Thursday it reached agreement to complete a purchase of Genentech, which began last year.
SAN FRANCISCO, Jan. 30 (UPI) -- Swiss pharmaceutical giant Roche said it would initiate a tender offer to take over U.S. biotechnology company Genentech.
SOUTH SAN FRANCISCO, Calif., Aug. 14 (UPI) -- Swiss pharmaceutical behemoth Roche will have to dig deeper into its pockets if it wants to own all of Genentech Inc., which rejected its $43.7 billion offer.
BASEL, Switzerland, July 21 (UPI) -- Swiss drugmaker Roche Holding AG has offered $43.7 billion -- $89 a share -- for the U.S. biotech firm Genentech.
SEOUL, Nov. 22 (UPI) -- Two South Korean companies have developed, separately, generic versions of the anti-flu drug Tamiflu.
BOMBAY, Oct. 14 (UPI) -- Mindful of likely legal hurdles, an Indian drug firm plans to make a generic version of an anti-flu vaccine whose patent is held by Swiss drug giant Roche.
LONDON, Aug. 12 (UPI) -- An anti-viral drug made by GlaxoSmithKline PLC should be stockpiled to protect against bird flu, a group of scientists told a British medical journal.
RENZBERG, Germany, July 5 (UPI) -- Swiss pharmaceutical company Roche will invest more than $500 million in two new biotechnology plants in Bavaria, a German daily reported Tuesday.
FOSTER CITY, Calif., June 24 (UPI) -- California's Gilead Sciences Inc. is pulling the license for its anti-flu drug Tamiflu from Swiss pharmaceutical giant Roche Holding AG.
BASEL, Switzerland, Jan. 14 (UPI) -- Roche Holding AG has announced the European Commission's approval of Avastin for patients with metatastic cancer of the colon or rectum.
